97357860
Apr 11, 2022
Pharmaceutical preparations containing tasimelteon for use in the treatment of Autism Spectrum Disorder; Pharmaceutical preparations containing tasimelteon for use in the treatment of Delayed Sleep Phase Disorder; Pharmaceutical preparations containing tasimelteon for use in the treatment of Jet Lag Disorder; Pharmaceutical preparations containing tasimelteon for use in the treatment of depression; Pharmaceutical preparations containing tasimelteon for use in the treatment of Major Depressive Disorder
Pharmaceuticals